154 related articles for article (PubMed ID: 3571486)
1. Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model.
Wikstrand CJ; McLendon RE; Carrel S; Kemshead JT; Mach JP; Coakham HB; de Tribolet N; Bullard DE; Zalutsky MR; Bigner DD
J Neuroimmunol; 1987 May; 15(1):37-56. PubMed ID: 3571486
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
3. Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies (MAbs).
Bullard DE; Wikstrand CJ; Humphrey PA; Lee YS; Coleman RE; Zalutsky M; Bigner DD
Nuklearmedizin; 1986 Dec; 25(6):210-5. PubMed ID: 3808960
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis.
Bourdon MA; Coleman RE; Blasberg RG; Groothuis DR; Bigner DD
Anticancer Res; 1984; 4(3):133-40. PubMed ID: 6465851
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.
Lee YS; Bullard DE; Zalutsky MR; Coleman RE; Wikstrand CJ; Friedman HS; Colapinto EV; Bigner DD
Cancer Res; 1988 Feb; 48(3):559-66. PubMed ID: 2446747
[TBL] [Abstract][Full Text] [Related]
6. The localisation of radiolabelled murine monoclonal antibody 81C6 and its Fab fragment in human glioma xenografts in athymic mice.
Colapinto EV; Lee YS; Humphrey PA; Zalutsky MR; Friedman HS; Bullard DE; Bigner DD
Br J Neurosurg; 1988; 2(2):179-91. PubMed ID: 3267302
[TBL] [Abstract][Full Text] [Related]
7. Regional localization of a glioma-associated antigen defined by monoclonal antibody 81C6 in vivo: kinetics and implications for diagnosis and therapy.
Blasberg RG; Nakagawa H; Bourdon MA; Groothuis DR; Patlak CS; Bigner DD
Cancer Res; 1987 Aug; 47(16):4432-43. PubMed ID: 3607773
[TBL] [Abstract][Full Text] [Related]
8. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
Lee Y; Bullard DE; Humphrey PA; Colapinto EV; Friedman HS; Zalutsky MR; Coleman RE; Bigner DD
Cancer Res; 1988 May; 48(10):2904-10. PubMed ID: 2452014
[TBL] [Abstract][Full Text] [Related]
9. Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.
Colapinto EV; Humphrey PA; Zalutsky MR; Groothuis DR; Friedman HS; de Tribolet N; Carrel S; Bigner DD
Cancer Res; 1988 Oct; 48(20):5701-7. PubMed ID: 3167830
[TBL] [Abstract][Full Text] [Related]
10. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
Schuster JM; Garg PK; Bigner DD; Zalutsky MR
Cancer Res; 1991 Aug; 51(16):4164-9. PubMed ID: 1714341
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
Zalutsky MR; Noska MA; Colapinto EV; Garg PK; Bigner DD
Cancer Res; 1989 Oct; 49(20):5543-9. PubMed ID: 2477144
[TBL] [Abstract][Full Text] [Related]
12. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
13. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
[TBL] [Abstract][Full Text] [Related]
14. Tumor localization of human brain malignant glioma xenograft in nude mice with a radiolabeled monoclonal antibody.
Lee WH; Yeh MY; Tu YC
Neurosurgery; 1990 Mar; 26(3):381-90. PubMed ID: 2320206
[TBL] [Abstract][Full Text] [Related]
15. Comparison of monoclonal antibody delivery to intracranial glioma xenografts by intravenous and intracarotid administration.
Lee YS; Bullard DE; Wikstrand CJ; Zalutsky MR; Muhlbaier LH; Bigner DD
Cancer Res; 1987 Apr; 47(7):1941-6. PubMed ID: 3815382
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies.
Bullard DE; Adams CJ; Coleman RE; Bigner DD
J Neurosurg; 1986 Feb; 64(2):257-62. PubMed ID: 3944636
[TBL] [Abstract][Full Text] [Related]
17. Chimeric anti-tenascin antibody 81C6: increased tumor localization compared with its murine parent.
Zalutsky MR; Archer GE; Garg PK; Batra SK; Bigner DD
Nucl Med Biol; 1996 May; 23(4):449-58. PubMed ID: 8832699
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin.
He X; Archer GE; Wikstrand CJ; Morrison SL; Zalutsky MR; Bigner DD; Batra SK
J Neuroimmunol; 1994 Jul; 52(2):127-37. PubMed ID: 7518471
[TBL] [Abstract][Full Text] [Related]
19. The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody.
Hauck ML; Zalutsky MR
Clin Cancer Res; 1998 Sep; 4(9):2071-7. PubMed ID: 9748121
[TBL] [Abstract][Full Text] [Related]
20. Targeting of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Wharam MD; Order SE; Wanek PM; Poggenburg JK; Klein JL
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1367-75. PubMed ID: 2370186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]